BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-426@pharmaconomics
DTSTAMP:20260707T015521Z
DTSTART;VALUE=DATE:20260410
DTEND;VALUE=DATE:20260411
SUMMARY:REPL CRL — RP1 (vusolimogene oderparepvec)
DESCRIPTION:An FDA complete response letter on RP1 (vusolimogene oderparepvec) for advanced melanoma is in focus around Apr 10\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1737953/000110465926042141/tm2611633d1_8k.htm\n\nTrack it: https://pharmaconomics.com/e/426
URL:https://pharmaconomics.com/e/426
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:REPL catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR